Product Discontinuation Notification – Ampicillin for Injection, USP 2 g VialRead more about Product Discontinuation Notification – Ampicillin for Injection, USP 2 g Vial
Notification of Emergency Date Extension for Dobutamine in 5% Dextrose Injection, USP Flexible Container and Dobutamine Injection, USP Single Dose Vial, Multiple PresentationsRead more about Notification of Emergency Date Extension for Dobutamine in 5% Dextrose Injection, USP Flexible Container and Dobutamine Injection, USP Single Dose Vial, Multiple Presentations
Product NDC and Packaging Change for Propofol Injectable Emulsion, USP (contains Benzyl Alcohol) 200 mg/20 mL (10 mg/mL) Single Patient Use Glass Fliptop VialRead more about Product NDC and Packaging Change for Propofol Injectable Emulsion, USP (contains Benzyl Alcohol) 200 mg/20 mL (10 mg/mL) Single Patient Use Glass Fliptop Vial
Product NDC and Packaging Change for Marcaine™ Spinal (0.75% bupivacaine hydrochloride in dextrose injection, USP) 15 mg/2 mL (7.5 mg/mL) Glass AmpulRead more about Product NDC and Packaging Change for Marcaine™ Spinal (0.75% bupivacaine hydrochloride in dextrose injection, USP) 15 mg/2 mL (7.5 mg/mL) Glass Ampul
Pfizer Hospital Product Return-to-Market: Depo-Medrol® (methylprednisolone acetate injectable suspension, USP), Multiple PresentationsRead more about Pfizer Hospital Product Return-to-Market: Depo-Medrol® (methylprednisolone acetate injectable suspension, USP), Multiple Presentations
Notification of Emergency Date Extension for Heparin Sodium in 5% Dextrose Injection 25,000 USP Units/250 mL (100 USP Units/mL) Flexible ContainerRead more about Notification of Emergency Date Extension for Heparin Sodium in 5% Dextrose Injection 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container
Notification of Label Change for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) Multiple Dose VialRead more about Notification of Label Change for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) Multiple Dose Vial
